Skip to main content
OpenTrials

Clinical trial condition

Glomerulonephritis

Explore clinical trials studying Glomerulonephritis. Study availability and eligibility vary by location and protocol.

496 public trials 165 recruiting studies
Refine in advanced search Browse all conditions

Glomerulonephritis trial results

Recruiting

A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

NCT07015983

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • Local Institution - 0106 Phoenix, Arizona, United States
  • Local Institution - 0038 Los Angeles, California, United States
  • Local Institution - 0051 Los Angeles, California, United States
  • Local Institution - 0093 Newport Beach, California, United States
View all 96 locations
View Trial Details
Recruiting

A Study to Assess the Effects of Zigakibart on IgA Nephropathy.

NCT07146906

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations
  • Colorado Kidney Care Nephrology Denver, Colorado, United States
  • American Clinical Trials Acworth, Georgia, United States
  • Univ Of Iowa Hospitals And Clinics Iowa City, Iowa, United States
  • Inter Med Consultants Edina, Minnesota, United States
View all 26 locations
View Trial Details
Recruiting

Personalized Rituximab Treatment Based on Artificial Intelligence in Membranous Nephropathy (iRITUX)

NCT06341205

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • CHU de BESANCON Besançon, France
  • CHU de BORDEAUX - Hôpital Pellegrin Bordeaux, France
  • CHU de CAEN Caen, France
  • AP-HP - Hôpital H. Mondor Créteil, France
View all 14 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

NCT05797610

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Alabama Kidney Research - ERN - PPDS Alabaster, Alabama, United States
  • UAB Nephrology Research Clinic Birmingham, Alabama, United States
  • Sunrise Medical Management LLC Surprise, Arizona, United States
  • Tucson Neuroscience Research - M3 WR Tucson, Arizona, United States
View all 204 locations
View Trial Details
Recruiting

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

NCT07611214

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • Purushotham & Akther Kotha MD, Inc. La Mesa, California, United States
  • Valerius Medical Group & Research Center of Greater Long Beach, Inc. Los Alamitos, California, United States
  • Swati Shah MD Rheumatology, LLC Jacksonville, Florida, United States
  • CTR Oakwater Orlando, Florida, United States
View all 15 locations
View Trial Details

Related conditions